Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 22Gastrointestinal 16Gynecologic 5Head & Neck 4Tumor-Agnostic 3Thoracic 3Other hematologic neoplasm 2Genitourinary 2Endocrine 2Other solid neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Lymphoma, Follicular 1Cognitive Dysfunction 1Brain Injuries, Traumatic 1

Interventions

Rituximab 702Cyclophosphamide 643Vincristine 352Doxorubicin 307Etoposide 303Cytarabine 270Filgrastim 250Prednisone 248Methotrexate 240fludarabine phosphate 231Dexamethasone 208fludarabine 183Peripheral Blood Stem Cell Transplantation 165Radiotherapy 160Granulocyte Colony-Stimulating Factor 145Lenalidomide 144Bendamustine Hydrochloride 142Bortezomib 127Melphalan 126ibrutinib 111Busulfan 110Mycophenolic Acid 107Whole-Body Irradiation 106Tacrolimus 96Cyclosporine 86Gemcitabine 82Ifosfamide 80Alemtuzumab 80Calcium Dobesilate 79Leucovorin 77

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Control Groups × Lymphoid × Clear all
NCT03092713 2021-10-19

Combined Cognitive and Vocational Interventions After Mild-to-moderate TBI: a Randomized Controlled Trial

Oslo University Hospital

Phase NA Completed
121 enrolled
Lymphoid

Brain Injuries, Traumatic, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡